Search

Wang, Z., Z. Cheng, V. Cristofaro, J. Li, X. Xiao, P. Gomez, R. Ge, et al. 2012. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes.

Fendt, S. M., E. L. Bell, M. A. Keibler, S. M. Davidson, G. J. Wirth, B. Fiske, J. R. Mayers, et al. 2013. Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism.

Olumi, A. F., D. S. Kaufman, A. Zietman, M. G. Harisinghani, and C. L. Wu. 2013. Case Records of the Massachusetts General Hospital. Case 25-2013. A 71-Year-Old Man With Hematuria and a Mass in the Bladder.

Aizer, A. A., J. J. Paly, M. D. Michaelson, S. K. Rao, P. L. Nguyen, I. D. Kaplan, A. Niemierko, A. F. Olumi, and J. A. Efstathiou. 2014. Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer.

Preston, M. A., A. H. Riis, V. Ehrenstein, R. H. Breau, J. L. Batista, A. F. Olumi, L. A. Mucci, H. O. Adami, and H. T. Sørensen. 2014. Metformin Use and Prostate Cancer Risk.

Rodríguez, D., M. A. Preston, G. W. Barrisford, A. F. Olumi, and A. S. Feldman. 2014. Clinical Features of Leiomyosarcoma of the Urinary Bladder: Analysis of 183 Cases.

Ingham, M. D., R. J. Lee, D. MacDermed, and A. F. Olumi. 2018. Prostate Cancer in Transgender Women.

Wang, Z., and A. F. Olumi. 2018. Metformin: an Antiproliferative Agent and Methylation Regulator in Treating Prostatic Disease?.

Wu, S., J. Ye, Z. Wang, S. X. Lin, M. Lu, Y. Liang, X. Zhu, A. F. Olumi, W. D. Zhong, and C. L. Wu. 2018. Expression of Aromatase in Tumor Related Stroma Is Associated With Human Bladder Cancer Progression.

Yun, H., R. Bedolla, A. Horning, R. Li, H. C. Chiang, T. H. Huang, R. Reddick, A. F. Olumi, R. Ghosh, and A. P. Kumar. 2018. BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.